Rays Exercise Rasmussen's Record $20M Option — Could a Trade Follow?
GOATIFYTampa Bay just made a decision that would be ordinary for a financial heavyweight and extraordinary for the Rays. The reigning American League champions exercised Drew Rasmussen's $20 million option for 2027, committing to a single-season salary larger than any the franchise has previously paid. The right-hander has earned it on the mound. Whether the organization can carry that commitment all the way to Opening Day is a more complicated question.
Rasmussen went 16-5 with a 2.67 ERA, 174 strikeouts and 172 innings in 30 regular-season starts, then helped carry Tampa Bay to the World Series. His option had originally been worth $8 million; performance and availability escalators pushed it to $20 million. The Rays could have walked away for a $500,000 buyout. Instead, they kept the pitcher who became their most dependable starter, even as other pieces of their rotation head toward free agency.
There are two stories here. One is the remarkable return of a pitcher who has endured three major elbow operations and become a genuine ace. The other is the financial and roster dilemma facing a club that has built its identity on finding elite production without routinely paying elite prices. Picking up the option answers the first contract question. It does not settle every question about Rasmussen's future.
A $20 Million Option Is a Franchise Record — and a Calculated Choice
Start with the numbers that make the decision so unusual. Tampa Bay could have declined Rasmussen's 2027 option and paid a $500,000 buyout. Instead, it committed $20 million for one season, the first time in franchise history the Rays have reached that figure for an individual player's annual salary. Charlie Morton's $15 million salary in 2019 had been the previous single-season high. For a club whose competitive advantage has often been its ability to assemble effective pitching at comparatively modest prices, that is a meaningful threshold.
The contract was not originally designed as a straightforward $20 million guarantee. Rasmussen signed a two-year, $8.5 million agreement in January 2025 to avoid arbitration. His 2027 club option began at $8 million and contained escalators tied to performance and availability. By making 30 starts and delivering a healthy, full workload in 2026, he triggered the conditions that lifted the option to its maximum value. The increased salary is therefore not a surprise negotiation after the World Series. It is the result of an agreement the Rays made when the risk around his health was greater.
That distinction matters. A team option gives the club the choice, not the obligation, to pay the specified amount. Tampa Bay had to weigh the salary against what a pitcher of Rasmussen's caliber might cost on the open market, the risk of another injury and the value of retaining control for a year in which the rest of the rotation is changing. The front office decided that paying the escalated figure was preferable to losing its ace for a comparatively small buyout.
But exercising the option is not equivalent to signing a multiyear extension or issuing a no-trade promise. Rasmussen can become a free agent after the 2027 season, and the club still controls a tradable contract. That makes this both a baseball decision and an asset-management decision. Tampa Bay has secured one year of a top starter at a fixed price. It has not committed itself to keeping him indefinitely, and it has not eliminated the possibility that another team might value that year even more highly.
The temptation is to treat the $20 million headline as evidence that the Rays have suddenly abandoned their operating model. A single option decision cannot establish that. What it does establish is that they recognized an unusual combination of quality, scarcity and contractual leverage. The harder test is whether they will absorb the cost in a competitive 2027 roster or decide that the return in a trade could help them sustain the next version of their team.
The 2026 Numbers Explain Why Tampa Bay Couldn't Simply Walk Away
Rasmussen's regular season made a strong argument before the postseason even began. He finished 16-5 with a 2.67 ERA, 174 strikeouts and 172 innings across 30 starts. Those were career highs in workload and strikeouts, and he led the American League with a WHIP of approximately 0.91. The combination is more revealing than the win-loss record alone: he limited traffic on the bases, sustained effectiveness over a full starter's schedule and gave manager Kevin Cash a reliable option in a rotation built around careful workload planning.
His efficiency was not a one-season illusion. Since the beginning of 2022, Rasmussen's 2.74 ERA ranks among the lowest for pitchers with at least 500 innings in that period. That longer sample matters because one excellent year can be influenced by sequencing, defense and the quality of opponents. Several seasons of run prevention against major-league hitters are a more persuasive reason to commit significant money. Tampa Bay was not buying a brief October hot streak; it was paying for a body of work that had survived changing roles and significant medical setbacks.
Then came the games that changed how the rest of baseball viewed his ceiling. In the Division Series against the Yankees, Rasmussen took a no-hitter into the eighth inning, struck out 10 and helped deliver a 1-0 victory. He was part of the pitching foundation that carried the Rays through the American League bracket and into their third World Series. Across five postseason starts, he finished 2-1 with a 2.20 ERA in 28 2/3 innings. That is a meaningful sample under pressure, even if no short October run should be mistaken for a guarantee about the following year.
The World Series provided a less tidy ending. Rasmussen allowed three runs in 3 2/3 innings in Game 2, then returned on three days' rest to start Game 5 with Tampa Bay facing elimination. He permitted one run on two hits over four innings, striking out four without a walk. The Rays still lost 4-1 as Milwaukee clinched its first championship. Recording the loss did not make him the cause of the defeat. His final outing was efficient within a deliberately limited workload, while the offense could not overcome the Brewers' pitching.
For a front office evaluating the option, the season offers a coherent picture: elite prevention of baserunners, a career-best innings total, repeated postseason success and a pitcher who was trusted with the ball when the season was on the line. The World Series loss hurts, but it does not materially weaken the argument that Rasmussen was one of the American League's most valuable starters. Paying him a premium for one more year is defensible on performance alone.
Three Elbow Surgeries Make the Rays' Workload Plan Part of His Value
The health history behind this option is not a footnote. Rasmussen underwent Tommy John surgeries in 2016 and 2017, then required an internal brace procedure in 2023. The third operation interrupted his career just as he was establishing himself as a dependable major-league starter. He returned in 2024 in a shorter multi-inning role before building back toward a normal rotation workload. For many pitchers, that sequence would create lasting uncertainty about whether they could handle 30 starts again.
Tampa Bay approached the comeback by treating availability as something to be managed rather than taken for granted. The Rays frequently gave Rasmussen more than the traditional four days between starts. That extra rest was not an admission that he lacked the stuff to compete; it was a way of increasing the chance that the stuff would still be there late in the year. By October, the club had been rewarded with 172 regular-season innings and a series of postseason starts in which he remained effective against the best opponents in the league.
Game 5 of the World Series crystallized the relationship. Rasmussen wanted to pitch again with the season at stake, even though he had started Game 2 only days earlier. Cash and the staff set a firm boundary of four innings or roughly 60 pitches. He was removed after four efficient innings and 48 pitches. The decision could look conservative to fans watching a must-win game, but it was consistent with the plan that helped make Rasmussen available for the World Series in the first place.
The trust runs in both directions. Rasmussen publicly expressed appreciation for the way the organization had protected him, even while acknowledging the business uncertainty around his future. That is not evidence that he has been promised a lifetime place in the rotation. It is evidence that the medical and performance relationship between pitcher and club has value beyond the box score. A new team could acquire his contract and his talent, but it would still need to understand how best to maintain his health and effectiveness.
There is no responsible way to guarantee that three past operations will never affect him again. Equally, it would be unfair to assume that his injury history makes another setback inevitable. His 2026 season demonstrated that a carefully structured workload can coexist with ace-level performance. The Rays' decision to exercise the option suggests they believe the risk is worth accepting for one more year. The question for 2027 is whether the same balance of rest, preparation and high-leverage usage can be sustained as the roster around him changes.
With Martinez and Peralta Departing, Keeping the Ace Is Only the First Roster Decision
It is impossible to assess the $20 million decision without looking at the pitchers Tampa Bay may have to replace. Nick Martinez and Freddy Peralta have moved into free agency after helping the Rays reach the World Series. Peralta's revival and October contributions made him a central figure in the club's pennant run, while Martinez supplied innings and flexibility. Their departures leave the organization facing an unusually complicated offseason: a proven ace is under contract, but the surrounding rotation cannot simply be copied from the team that won 98 games.
That is the strongest argument for retaining Rasmussen. A team expecting to contend again cannot assume that inexpensive replacements will immediately match the output of several established starters. Rasmussen gives Cash a known standard at the front of the rotation and reduces the pressure on younger pitchers who may need time to grow into larger roles. In a division where small changes in starting-pitching quality can determine a playoff place, the certainty of one ace has real competitive value.
There is also a credible counterargument. The Rays have historically been willing to move expensive or soon-to-be-expensive players when the return strengthens the organization over multiple seasons. Rasmussen's contract is limited to one year, and he could reach free agency after 2027. If another club offered several years of controllable talent or premium prospects, Tampa Bay would have to compare that package with the value of one more season of elite pitching. Considering that possibility is not the same as reporting that trade talks are underway. No completed trade or agreement has been established.
The club's broader payroll picture makes the choice more complicated. A $20 million salary consumes a larger share of a smaller-market budget than it would for the Yankees or Dodgers. Every dollar committed to the ace is a dollar unavailable for a replacement starter, a veteran bat or bullpen depth unless ownership expands the overall spending plan. The Rays could choose to absorb the expense because they are coming off an American League title, or they could view the exercised option as a way to preserve maximum negotiating leverage before making a trade. Both paths are consistent with the business logic of retaining an asset rather than letting him leave for a buyout.
Fans should resist treating the contract as either an unconditional promise or a signal that a trade is inevitable. The most important evidence will come from the rest of the offseason: how aggressively Tampa Bay replaces departing arms, whether it adds affordable depth, and whether the front office speaks about Rasmussen as the foundation of its next rotation. The decision to pay him is real. The final shape of the 2027 staff is still unknown. A franchise-record salary has bought the Rays an opportunity to choose; it has not made the choice for them.
The Rays did not guarantee that Drew Rasmussen will pitch for them throughout 2027 by exercising his option. They guaranteed that the right to his next season has real value. At $20 million, it is the largest single-year salary commitment the franchise has made, but the performance behind it is substantial: an ace-caliber regular season, a run to the American League pennant and a postseason that proved he could handle the highest pressure.
Tampa Bay's next move will reveal whether this is a departure from its usual payroll discipline or another example of it. Retaining Rasmussen would give the Rays a proven anchor while they rebuild around departing pitchers. Trading him would be an unmistakable reminder that the club can treat even its most beloved and productive players as movable assets. For now, the player who wanted to stay has his option exercised. That is good news. It is not yet the final chapter.
